To make an appointment, please call 1-800-KARMANOS (1-800-527-6266) or request an appointment online
As a leader in cancer research, Karmanos is able to offer patients access to innovative treatments and clinical trials that are often times not available anywhere else.
To offer hope and longer life to patients with all types of cancer, Karmanos offers the latest types of therapy through our clinical trials program. Through clinical trials, we are creating new knowledge about how therapies fight cancer and provide national leadership in testing these new therapies.
We understand that cancer is a complex disease that demands complex care. We provide each patient with a dynamic, carefully constructed treatment plan focused on their specific cancer and their unique needs.
We listen to you to design a plan that provides you with respect, compassionate care and is responsive to your emotional and practical concerns.
Phone: 517-913-3890
Karmanos Cancer Institute at McLaren Greater Lansing is the leader in cancer care, treatment, diagnostics, education, clinical trials and research. Karmanos is your best chance in the fight against cancer.
Oncology - Radiation
Oncology - Hematology
Oncology - Gynecologic
Oncology - Hematology, Physician Assistant
Oncology - Hematology, Oncology - Medical
Genetics
Gene Hodulik
Karmanos Cancer Institute
John Lacks
Baljinder Khuban
Over the past 17 months, Karmanos Cancer Institute has worked tirelessly to ensure that our patients and staff are informed about changes to care ...
Congratulations to Phil Incarnati and Dr. Gerold Bepler! Every year, dBusiness Magazine highlights the 500 most influential business leaders in me...
KSP Specialty Pharmacy is pleased to announce that it has achieved accreditation through the Accreditation Commission for Health Care (ACHC) for i...
With everything going on in the world it may be hard to establish healthy sleep habits, but it’s more important than ever to make sure you are pra...
Lung cancer is the leading cause of cancer death and the second most common cancer among both men and women in the United States, according to the...